Problem Set 8 Key 1 of 8
|
|
- Loren Henderson
- 5 years ago
- Views:
Transcription
1 Problem Set 8 Key 1 of Problem Set 8 Key 1. As a bright MD/PhD, you are interested in questions about the control of cell number in the body. Recently, you've seen three patients with abnormally high amounts of T-cells and concurrent autoimmune disease, where the body's immune system begins to attack itself. To understand why these patients are ill, you isolate T-cells from them and begin to study the cells in the lab to determine what particular mutations are causing disease. a. Why might the patients have abnormally high levels of T-cells? overproliferation or defect in apoptosis b. You begin to study the cells in culture and first decide to look at the protein Caspase-9 by Western blotting, since you have a good antibody available. You make protein extracts from all cell lines in the presence or absence of trophic factors, run the extracts out on an SDS-PAGE gel, transfer to a membrane and probe the membrane with anti-caspase-9. Your results are shown below: WT Mut 1 Mut 2 Mut 3 Cell Strain Trophic Factor What can you conclude about mutant cell lines 1 and 2? the apoptotic pathway is not being activated properly in the absence of trophic factor, as caspase-9 is not cleaved into its active state. furthermore, the mutations in patients 1 and 2 are in the apoptotic pathway upstream of caspase 9 activation (so, loss of function in Bax, Apaf1, Cytochrome C, Bad, a constitutively active mutation in either PI-3 or AKT kinase, or even a dominant negative mutation in Bcl-2/Bcl-xl could be responsible for the lack of apoptosis) c. You find that the cells isolated from patient 3 never undergo apoptosis, even under extreme conditions of hypoxia and gamma irradiation. It seems that patient 3 has a mutation in their apoptotic pathway, so which gene
2 Problem Set 8 Key 2 of 8 might you conclude the mutation affected, given the data in b? How could you test this hypothesis experimentally? the mutation may affect Caspase-3, as Caspase-9 is properly cleaved and presumably activated in these cells in the absence of trophic factor. to test this, you would perform a rescue experiment in which you transfected the gene encoding a wt copy of caspase-3 into the mutant cells, and make wt protein in the cells (not overexpression!). then you would check to see if they were able to do apoptosis in the absence of trophic factor. if the mutation affected caspase-3, the cells with the new wt gene should now be able to apoptose when growth factor was removed. d. You return to mutants 1 and 2 and check to see if the Bax protein is affected. The experiment you perform is a Co-IP, where you use anti-bax antibodies to do the immunoprecipitation and then do a Western blot to look at Bcl-2 binding to Bax. You first probe your blot with anti-bax to make sure the IP worked and then strip the anti-bax antibody from it and reprobe the blot with anti-bcl-2. Both blots are shown below: WT Mut 1 Mut 2 Cell Strain Trophic Factor Bax Bcl-2 What genes could be mutated in patients 1 and 2, using this data and the data in b? Both mutants seem to undergo activation of the apoptotic pathway just fine up to the point where Bax is released from inhibition by Bcl- 2 binding, but then fail to cleave and activate Caspase-9 (from b), so the mutation could affect any genes acting in the pathway between those Bax and Caspase-9 (Bax itself, Cytochrome c, Apaf1, Caspase- 9 itself). e. You discover that the mutant 2 cells (but not the mutant 1 cells) have a dramatically decreased respiration rate in addition to the defect in apoptosis. What gene is the mutation affecting?
3 Problem Set 8 Key 3 of 8 Cytochrome c is mutated. This protein would give both the apoptotic defect of not cleaving Caspase-9, since it is needed to help Apaf1 activate the cleavage of Caspase-9, and the respiration defect, since it is necessary for the electron transport in the mitochondria during cellular respiration. f. Propose an experiment to determine which gene is affected in mutant 1. We have the possible genes narrowed to Bax, Apaf1, or Caspase-9 at this point, so we could transfect into the mutant cells the wt gene for each of these and then ask if they undergo apoptosis when trophic factor is removed, as we did in c above. 2. Besides there being induction of apoptosis when trophic factors are removed, there are pathways in which a death ligand (e.g. CD95/FasL) binds to a death receptor and signals the activation of regulator Caspases like Caspase-9, which then activate other Caspases like Caspase-3. You isolate some leukemic cells from several patients which you think are defective in apoptosis and treat them with the anti-cancer drug doxorubicin, which promotes the production of death ligand. Your results follow: WT Mut A Mut B cell strain doxorubicin yes no yes no no no Undergo Apoptosis? a. What part of the "death pathway" might be affected in Mut A? there may be not enough ligand produced and doxorubicin stimulates production of enough ligand to get apoptosis to occur. b. What part of the "death pathway" might be affected in Mut B? the receptor or the downstream components like regulator caspases (like caspase-9), or even effector caspases like caspase What would you expect to happen in a normal cell line when the following proteins were expressed at the designated levels: Protein expressed + Trophic Factor - Trophic Factor Overexpress Bcl-2 that No Apoptosis No Apoptosis, acts as will not release Bax a dominant negative Overexpress Bad that doesn't bind Bcl-2 No Apoptosis Apoptosis, as some wildtype Bad remains
4 Problem Set 8 Key 4 of 8 Express at normal levels a Bad protein with S to D mutations at its phosphorylation sites Express at normal levels a truncated Caspase-9 that looks like the cleaved form of the protein Express at normal levels a Caspase-9 mutant that has an aspartate to alanine mutation Apoptosis Apoptosis, this seems to be a constitutive form of Caspase-9 that can activate Caspase-3 all the time No Apoptosis and can inhibit Bcl-2 No Apoptosis, as this protein acts as phosphorylated Bad, which cannot bind Bcl-2 and is probably sequestered by Apoptosis Apoptosis, even though this mutant cannot be activated because its cleavage site is mutated, there is still WT caspase-9 to do the job. 4. You are a gifted grad student, pursuing four different thesis projects, which requires you to use four different cell lines. Feeling ever so slightly sleep deprived, you mislabel your flasks of cells one night. No problem, I can fix this like I always do, you think, especially since these cells are of four pretty different types: tumor cells, primary fibroblasts, mouse embryonic stem cells, and an immortalized cell line from mouse intestines. a. What characteristics of these cells might you check to distinguish between them? you would ask: do they display density dependent inhibition, are they anchorage dependent (require ECM), do they display loss of apoptotic controls, have they acquired telomerase activity, can they mimic metastasis (degrade ECM), do they require growth factor to divide, can they be induced to differentiate b. What experiments might you perform to determine if each cell line displays these characteristics in a? take a fraction of your cells to perform the following experiments, making sure to keep them growing to do your real experiments when you get this sorted out...
5 Problem Set 8 Key 5 of 8 density dependent inhibition: grow cells to confluency, check to see if they begin to grow on top of each other or if they stop growing when they begin to touch each other. anchorage dependence: grow cells with and without ECM components (fibroblast helper cells which secrete ECM), cells which don't require ECM will live, those which do require ECM will die loss of apoptotic controls: grow cells under normal conditions and condition like hypoxia, gamma irradiation, removal of trophic factor, which would induce apoptosis normally. then perform an assay like TUNEL or fluorescent antibody staining for the cleaved form of caspase-3, and look at under the microscope to determine if any of the cells undergo apoptosis under the apoptosis-inducing conditions. have they acquired telomerase activity: perform a telomerase assay using extracts from each of the cell lines (don't need to know the details of the assay, just that it measures telomerase activity) degradation of ECM: incubate the cells with ECM components, then recover the extracellular medium with ECM components, run SDS- PAGE and Western Blot for breakdown of laminins, fibronectins, collagen require growth factor to divide: grow the cells in the absence of growth factor and see if they survive can they be induced to differentiate: grow cells in the presence of differentiation factors like Epo and see if they begin to differentiate c. What might you expect from each cell line in terms of these characteristics? Tumor Cells: density independent growth, may not require ECM, may degrade ECM, grow in absence of growth factor, would not differentiate, lost apoptotic controls, may have telomerase activity Primary Fibrobalsts: density dependent growth, make their own ECM, don't degrade ECM, require growth factor, may differentiate, have apoptotic controls intact, no telomerase activity Embryonic Stem Cells:
6 Problem Set 8 Key 6 of 8 require ECM, don't degrade ECM, require growth factors, differentiate, have apoptotic controls inact, telomerase active, density independent growth Immortalized Intestine Cells: density dependent inhibition, require ECM, don't degrade ECM, may not require growth factors, active telomerase likely, don't differentiate, may have apoptotic controls intact. 5. You are performing a screen for mutations in genes that could cooperate with the c-myc oncogene. To do this, you make use of a transgenic mouse that contains a c-myc oncogene under the control of a strong promoter. These mice express high levels of c-myc and develop several types of tumors only after a variable latency period. You then infect these mice with a slow-acting carcinogenic retrovirus, which integrates itself into tht host genome, and observe the following: 100% % tumor-free mice 75% 50% 25% 0% myc + + retrovirus myc Age in days a. What is the effect of the retrovirus infection in myc + mice? The retrovirus infection reduces the latency period of the onset of tumors in the myc + mice. b. What is the mechanism by which the retrovirus allow you to identify other oncogenes that synergize with the c-myc oncogene? The retrovirus inserts itself in the myc + mice genome more or less at random. If the virus is inserted near a promoter or enhancer region of a proto-oncogene, this could lead to this proto-oncogene to become overexpressed turning it into an oncogene. WT
7 Problem Set 8 Key 7 of 8 You cloned the genomic DNA from a tumor flanking a proviral insertion. This same DNA sequence was found to be overexpressed in 21/29 tumors and codes for a novel gene which you call ccg for c-myc cooperating gene. c. How would you test in vitro if ccg functions as an oncogene that could synergize with c-myc? We can do a COLONY FORMATION ASSAY or SOFT AGAR ASSAY. In order to do this, we overexpress c-myc, ccg or c-myc + ccg in primary cells from wild-type mice and plate them on soft agar at low density. After several days of incubation, we count the number of colonies formed for each sample. If c-myc cooperates with ccg, c-myc + ccg should give a significantly higher number of colonies than c-myc or ccg alone. d. What would be a good positive control for the experiment proposed in c? Since ras is a known oncogene which cooperates with c-myc in the formation of tumors as well as colonies in soft agar, a c- myc + ras would be a good positive control. This sample should give you a significant number of colonies in this assay. Some of your mice develop melanomas which correlate with a very poor prognosis. These mice die shortly after and upon dissection, you discover that they had many tumors in different part of their bodies. You suspect that the original melanoma became metastatic and led to the accumulation of many other tumors. e. What would you do to test your hypothesis? We could isolate samples from the melanomas as well as the other tumors found in these mice. If these other tumors are due to metastasis of the original melanoma, we would expect that the melanoma has gained additional mutations which are the same as in the secondary tumors. However, the secondary tumors should contain more additional mutations which would confer them with their metastatic ability. 6. Two brothers are affected with a rare childhood cancer that can be cured. They are both succesfully treated and reach adulthood. One
8 Problem Set 8 Key 8 of 8 brother moves to the countryside whereas the second brother moves to an industrial city which is known to be a chemical waste dump. a. What would explain the difference in cancer incidence among the offspring of the two brothers? Both brothers are heterozygous for a germline tumor suppressor mutation which is passed on to roughly half of their offspring. The family that lives in the industrial city is exposed to more mutagens and therefore the offspring that inherited the mutant allele is much more likely to undergo loss of heterozygosity. b. Is it likely that the mutation has occurred in this pedigree? If so, in which individuals? Yes, because the two brothers are affected but neither of their parents are. The mutation could have arisen in any of their parents. c. Explain why a loss of function mutation of a tumor suppressor gene is recessive at the cellular level yet it shows dominant inheritance in families. In order to achieve loss of function of a tumor suppressor, two mutational events are required. In hereditary cancers, one mutation is inherited through the germline. This means that only one additional mutation is required, increasing its probability such that the penetrance of the dissease approaches 100%. So, even though the mutation is recessive, loss of heterozygosity makes the inheritance appear dominant.
Cancer. The fundamental defect is. unregulated cell division. Properties of Cancerous Cells. Causes of Cancer. Altered growth and proliferation
Cancer The fundamental defect is unregulated cell division. Properties of Cancerous Cells Altered growth and proliferation Loss of growth factor dependence Loss of contact inhibition Immortalization Alterated
More informationCancer. The fundamental defect is. unregulated cell division. Properties of Cancerous Cells. Causes of Cancer. Altered growth and proliferation
Cancer The fundamental defect is unregulated cell division. Properties of Cancerous Cells Altered growth and proliferation Loss of growth factor dependence Loss of contact inhibition Immortalization Alterated
More informationMolecular biology :- Cancer genetics lecture 11
Molecular biology :- Cancer genetics lecture 11 -We have talked about 2 group of genes that is involved in cellular transformation : proto-oncogenes and tumour suppressor genes, and it isn t enough to
More informationProgrammed Cell Death (apoptosis)
Programmed Cell Death (apoptosis) Stereotypic death process includes: membrane blebbing nuclear fragmentation chromatin condensation and DNA framentation loss of mitochondrial integrity and release of
More informationCANCER. Inherited Cancer Syndromes. Affects 25% of US population. Kills 19% of US population (2nd largest killer after heart disease)
CANCER Affects 25% of US population Kills 19% of US population (2nd largest killer after heart disease) NOT one disease but 200-300 different defects Etiologic Factors In Cancer: Relative contributions
More informationEarly cell death (FGF) B No RunX transcription factor produced Yes No differentiation
Solution Key - Practice Questions Question 1 a) A recent publication has shown that the fat stem cells (FSC) can act as bone stem cells to repair cavities in the skull, when transplanted into immuno-compromised
More informationC) The graph should look exactly like the graph on the left (Mut1 cells + Mating Pheromone for 3 hours at 25 degrees). The cells arrest in G1.
706-2000-Exam 4 Answer Key 1) The question asks you to explain peaks A and B in the top graph. The other two graphs were there to give you hints. The question did not ask for these other two graphs to
More informationBIO360 Fall 2013 Quiz 1
BIO360 Fall 2013 Quiz 1 1. Examine the diagram below. There are two homologous copies of chromosome one and the allele of YFG carried on the light gray chromosome has undergone a loss-of-function mutation.
More informationMultistep nature of cancer development. Cancer genes
Multistep nature of cancer development Phenotypic progression loss of control over cell growth/death (neoplasm) invasiveness (carcinoma) distal spread (metastatic tumor) Genetic progression multiple genetic
More informationIntroduction. Cancer Biology. Tumor-suppressor genes. Proto-oncogenes. DNA stability genes. Mechanisms of carcinogenesis.
Cancer Biology Chapter 18 Eric J. Hall., Amato Giaccia, Radiobiology for the Radiologist Introduction Tissue homeostasis depends on the regulated cell division and self-elimination (programmed cell death)
More informationSection D: The Molecular Biology of Cancer
CHAPTER 19 THE ORGANIZATION AND CONTROL OF EUKARYOTIC GENOMES Section D: The Molecular Biology of Cancer 1. Cancer results from genetic changes that affect the cell cycle 2. Oncogene proteins and faulty
More informationGenome of Hepatitis B Virus. VIRAL ONCOGENE Dr. Yahwardiah Siregar, PhD Dr. Sry Suryani Widjaja, Mkes Biochemistry Department
Genome of Hepatitis B Virus VIRAL ONCOGENE Dr. Yahwardiah Siregar, PhD Dr. Sry Suryani Widjaja, Mkes Biochemistry Department Proto Oncogen and Oncogen Oncogen Proteins that possess the ability to cause
More informationEarly Embryonic Development
Early Embryonic Development Maternal effect gene products set the stage by controlling the expression of the first embryonic genes. 1. Transcription factors 2. Receptors 3. Regulatory proteins Maternal
More informationDeregulation of signal transduction and cell cycle in Cancer
Deregulation of signal transduction and cell cycle in Cancer Tuangporn Suthiphongchai, Ph.D. Department of Biochemistry Faculty of Science, Mahidol University Email: tuangporn.sut@mahidol.ac.th Room Pr324
More informationProblem Set 5 KEY
2006 7.012 Problem Set 5 KEY ** Due before 5 PM on THURSDAY, November 9, 2006. ** Turn answers in to the box outside of 68-120. PLEASE WRITE YOUR ANSWERS ON THIS PRINTOUT. 1. You are studying the development
More informationTumor suppressor genes D R. S H O S S E I N I - A S L
Tumor suppressor genes 1 D R. S H O S S E I N I - A S L What is a Tumor Suppressor Gene? 2 A tumor suppressor gene is a type of cancer gene that is created by loss-of function mutations. In contrast to
More informationVIII Curso Internacional del PIRRECV. Some molecular mechanisms of cancer
VIII Curso Internacional del PIRRECV Some molecular mechanisms of cancer Laboratorio de Comunicaciones Celulares, Centro FONDAP Estudios Moleculares de la Celula (CEMC), ICBM, Facultad de Medicina, Universidad
More informationCancer and Gene Alterations - 1
Cancer and Gene Alterations - 1 Cancer and Gene Alteration As we know, cancer is a disease of unregulated cell growth. Although we looked at some of the features of cancer when we discussed mitosis checkpoints,
More informationc) Macrophages and B cells present antigens to helper T_-cells. (Fill in blanks.) 2 points
Question 1 You are an immunologist who wants to make the big bucks. You decide to leave the world of science and get a job as a script-consultant on a new medical drama (ER-like) show. You test the writers
More informationp53 and Apoptosis: Master Guardian and Executioner Part 2
p53 and Apoptosis: Master Guardian and Executioner Part 2 p14arf in human cells is a antagonist of Mdm2. The expression of ARF causes a rapid increase in p53 levels, so what would you suggest?.. The enemy
More informationTable S1. New colony formation 7 days after stimulation with doxo and VCR in JURKAT cells
Table S1. New colony formation 7 days after stimulation with and in JURKAT cells drug co + number of colonies 7±14 4±7 48±11 JURKAT cells were stimulated and analyzed as in Table 1. Drug concentrations
More information7.012 Quiz 3 Answers
MIT Biology Department 7.012: Introductory Biology - Fall 2004 Instructors: Professor Eric Lander, Professor Robert A. Weinberg, Dr. Claudette Gardel Friday 11/12/04 7.012 Quiz 3 Answers A > 85 B 72-84
More informationApoptosis Oncogenes. Srbová Martina
Apoptosis Oncogenes Srbová Martina Cell Cycle Control point Cyclin B Cdk1 Cyclin D Cdk4 Cdk6 Cyclin A Cdk2 Cyclin E Cdk2 Cyclin-dependent kinase (Cdk) have to bind a cyclin to become active Regulation
More informationMCB140: Second Midterm Spring 2010
MCB140: Second Midterm Spring 2010 Before you start, print your name and student identification number (S.I.D) at the top of each page. There are 11 pages including this page. You will have 150 minutes
More informationCh. 18 Regulation of Gene Expression
Ch. 18 Regulation of Gene Expression 1 Human genome has around 23,688 genes (Scientific American 2/2006) Essential Questions: How is transcription regulated? How are genes expressed? 2 Bacteria regulate
More informationSolution key Problem Set
Solution key- 7.013 Problem Set 7-2013 Question 1 a) Neuronal path finding is crucial for structured cellular organization and development of neural circuits. The elongation or retraction of the growth
More informationKaryotype analysis reveals transloction of chromosome 22 to 9 in CML chronic myelogenous leukemia has fusion protein Bcr-Abl
Chapt. 18 Cancer Molecular Biology of Cancer Student Learning Outcomes: Describe cancer diseases in which cells no longer respond Describe how cancers come from genomic mutations (inherited or somatic)
More informationSupplementary Figures
Supplementary Figures Supplementary Figure 1 Correlation between LKB1 and YAP expression in human lung cancer samples. (a) Representative photos showing LKB1 and YAP immunohistochemical staining in human
More informationActivation of cellular proto-oncogenes to oncogenes. How was active Ras identified?
Dominant Acting Oncogenes Eugene E. Marcantonio, M.D. Ph.D. Oncogenes are altered forms of normal cellular genes called proto-oncogenes that are involved in pathways regulating cell growth, differentiation,
More informationBIOL 4374/BCHS 4313 Cell Biology Exam #1 February 13, 2001
BIOL 4374/BCHS 4313 Cell Biology Exam #1 February 13, 2001 SS# Name This exam is worth a total of 100 points. The number of points each question is worth is shown in parentheses. Good luck! 1. (2) The
More informationChapter 4 Cellular Oncogenes ~ 4.6 -
Chapter 4 Cellular Oncogenes - 4.2 ~ 4.6 - Many retroviruses carrying oncogenes have been found in chickens and mice However, attempts undertaken during the 1970s to isolate viruses from most types of
More informationGenome 371, Autumn 2018 Quiz Section 9: Genetics of Cancer Worksheet
Genome 371, Autumn 2018 Quiz Section 9: Genetics of Cancer Worksheet All cancer is due to genetic mutations. However, in cancer that clusters in families (familial cancer) at least one of these mutations
More information7.013 Spring 2005 Problem Set 6
MIT Department of Biology 7.013: Introductory Biology - Spring 2005 Instructors: Professor Hazel Sive, Professor Tyler Jacks, Dr. Claudette Gardel NAME TA 7.013 Spring 2005 Problem Set 6 FRIDAY April 29th,
More informationoncogenes-and- tumour-suppressor-genes)
Special topics in tumor biochemistry oncogenes-and- tumour-suppressor-genes) Speaker: Prof. Jiunn-Jye Chuu E-Mail: jjchuu@mail.stust.edu.tw Genetic Basis of Cancer Cancer-causing mutations Disease of aging
More informationCell Division. non-mitotic cell. Dividing (mitotic) cell. (This movie has been sped up.) These chromosomes have been marked with RED fluorescence.
Cell Division These chromosomes have been marked with RED fluorescence. DNA is found in the cell nucleus Dividing (mitotic) cell non-mitotic cell (This movie has been sped up.) Cell Division and Cancer
More informationSUPPLEMENTARY INFORMATION
Figure S1 Treatment with both Sema6D and Plexin-A1 sirnas induces the phenotype essentially identical to that induced by treatment with Sema6D sirna alone or Plexin-A1 sirna alone. (a,b) The cardiac tube
More informationChapt 15: Molecular Genetics of Cell Cycle and Cancer
Chapt 15: Molecular Genetics of Cell Cycle and Cancer Student Learning Outcomes: Describe the cell cycle: steps taken by a cell to duplicate itself = cell division; Interphase (G1, S and G2), Mitosis.
More informationAgro/Ansc/Bio/Gene/Hort 305 Fall, 2017 MEDICAL GENETICS AND CANCER Chpt 24, Genetics by Brooker (lecture outline) #17
Agro/Ansc/Bio/Gene/Hort 305 Fall, 2017 MEDICAL GENETICS AND CANCER Chpt 24, Genetics by Brooker (lecture outline) #17 INTRODUCTION - Our genes underlie every aspect of human health, both in function and
More informationCELL BIOLOGY - CLUTCH CH CANCER.
!! www.clutchprep.com CONCEPT: OVERVIEW OF CANCER Cancer is a disease which is primarily caused from misregulated cell division, which form There are two types of tumors - Benign tumors remain confined
More informationSUPPLEMENTARY INFORMATION
SUPPLEMENTARY INFORMATION doi:1.138/nature9814 a A SHARPIN FL B SHARPIN ΔNZF C SHARPIN T38L, F39V b His-SHARPIN FL -1xUb -2xUb -4xUb α-his c Linear 4xUb -SHARPIN FL -SHARPIN TF_LV -SHARPINΔNZF -SHARPIN
More informationIntroduction: 年 Fas signal-mediated apoptosis. PI3K/Akt
Fas-ligand (CD95-L; Fas-L) Fas (CD95) Fas (apoptosis) 年 了 不 度 Fas Fas-L 力 不 Fas/Fas-L T IL-10Fas/Fas-L 不 年 Fas signal-mediated apoptosis 度降 不 不 力 U-118, HeLa, A549, Huh-7 MCF-7, HepG2. PI3K/Akt FasPI3K/Akt
More informationIntroduction to Cancer Biology
Introduction to Cancer Biology Robin Hesketh Multiple choice questions (choose the one correct answer from the five choices) Which ONE of the following is a tumour suppressor? a. AKT b. APC c. BCL2 d.
More informationProbe. Hind III Q,!?R'!! /0!!!!D1"?R'! vector. Homologous recombination
Supple-Zhang Page 1 Wild-type locus Targeting construct Targeted allele Exon Exon3 Exon Probe P1 P P3 FRT FRT loxp loxp neo vector amh I Homologous recombination neo P1 P P3 FLPe recombination Q,!?R'!!
More informationSupplementary Figures
Supplementary Figures Figure S1. Validation of kinase regulators of ONC201 sensitivity. Validation and screen results for changes in cell viability associated with the combination of ONC201 treatment (1
More information2015 AP Biology Unit #4 Test Cell Communication, Cancer, Heredity and The Cell Cycle Week of 30 November
Class: Date: 2015 AP Biology Unit #4 Test Cell Communication, Cancer, Heredity and The Cell Cycle Week of 30 November Multiple Choice 1 point each Identify the choice that best completes the statement
More informationBIO360 Fall 2013 Quiz 1
BIO360 Fall 2013 Quiz 1 Name: Key 1. Examine the diagram below. There are two homologous copies of chromosome one and the allele of YFG carried on the light gray chromosome has undergone a loss-of-function
More informationBIOL2005 WORKSHEET 2008
BIOL2005 WORKSHEET 2008 Answer all 6 questions in the space provided using additional sheets where necessary. Hand your completed answers in to the Biology office by 3 p.m. Friday 8th February. 1. Your
More informationBIO360 Quiz #1. September 14, Name five of the six Hallmarks of Cancer (not emerging hallmarks or enabling characteristics ): (5 points)
Name: BIO360 Quiz #1 September 14, 2012 1. Name five of the six Hallmarks of Cancer (not emerging hallmarks or enabling characteristics ): (5 points) 2. The controversial hypothesis that only a small subset
More informationA class of genes that normally suppress cell proliferation. p53 and Rb..ect. suppressor gene products can release cells. hyperproliferation.
Tumor Suppressor Genes A class of genes that normally suppress cell proliferation. p53 and Rb..ect Mutations that inactivate the tumor suppressor gene products can release cells from growth suppression
More informationDetermination of the temporal pattern and importance of BALF1 expression in Epstein-Barr viral infection
Determination of the temporal pattern and importance of BALF1 expression in Epstein-Barr viral infection Melissa Mihelidakis May 6, 2004 7.340 Research Proposal Introduction Apoptosis, or programmed cell
More informationC-Phycocyanin (C-PC) is a n«sjfc&c- waefc-jduble phycobiliprotein. pigment isolated from Spirulina platensis. This water- soluble protein pigment is
' ^Summary C-Phycocyanin (C-PC) is a n«sjfc&c- waefc-jduble phycobiliprotein pigment isolated from Spirulina platensis. This water- soluble protein pigment is of greater importance because of its various
More informationIKK-dependent activation of NF-κB contributes to myeloid and lymphoid leukemogenesis by BCR-ABL1
Supplemental Figures BLOOD/2014/547943 IKK-dependent activation of NF-κB contributes to myeloid and lymphoid leukemogenesis by BCR-ABL1 Hsieh M-Y and Van Etten RA Supplemental Figure S1. Titers of retroviral
More informationMITOCW S05-L29
MITOCW 7.013-S05-L29 And he took what was left, which much be very, very small, smaller than the size of a cell because the cells were removed by filtration, and he injected it into another bird. Now,
More informationIntroduction to Genetics
Introduction to Genetics Table of contents Chromosome DNA Protein synthesis Mutation Genetic disorder Relationship between genes and cancer Genetic testing Technical concern 2 All living organisms consist
More informationThe discovery of Bcl-2
The discovery of Bcl-2 Bcl-2: B-cell lymphoma 2 The pro-survival subfamily of Bcl-2 protein family Cloning of Bcl-2 as the oncogene which is deregulated at t(14;18) lymphomas Pioneer works by Tsujimoto
More information7.06 Cell Biology EXAM #3 April 24, 2003
7.06 Spring 2003 Exam 3 Name 1 of 8 7.06 Cell Biology EXAM #3 April 24, 2003 This is an open book exam, and you are allowed access to books and notes. Please write your answers to the questions in the
More informationTARGETS OF CYCLIN D1-CDK
TARGETS OF CYCLIN D1-CDK FIRST TARGET OF THE COMPLEX CYCLIN D-KINASI: prb, IS THE PRODUCT OF THE GENE CONFERRING SUSCEPTIBILITY TO RETINOBLASTOMA - ABSENT OR MUTATED IN SEVERAL HUMAN CANCERS - TRANSCRIPTIONL
More informationRegarding techniques of proteomics, there is:
Molecular الحلقة biology 14 واألخيرة To put you back in the context; the discussion was about Trancriptomics (the study of transcription). The following topic will be PROTEOMICS, which is the study of
More informationPREPARED FOR: U.S. Army Medical Research and Materiel Command Fort Detrick, Maryland
AD Award Number: DAMD17-03-1-0392 TITLE: The Role of Notch Signaling Pathway in Breast Cancer Pathogenesis PRINCIPAL INVESTIGATOR: Annapoorni Rangarajan, Ph.D. CONTRACTING ORGANIZATION: Indian Institute
More informationCancer genetics
Cancer genetics General information about tumorogenesis. Cancer induced by viruses. The role of somatic mutations in cancer production. Oncogenes and Tumor Suppressor Genes (TSG). Hereditary cancer. 1
More informationAnonymous MIT students MK and NM Natalie Kuldell May 2009
Anonymous MIT students MK and NM Natalie Kuldell 20.020 13 May 2009 Technical Document: oncocures Problem: Dynamic Metastasis Imaging Our project has been designed with the hope of creating a way to detect
More informationProblem Set #5 4/3/ Spring 02
Question 1 Chloroplasts contain six compartments outer membrane, intermembrane space, inner membrane, stroma, thylakoid membrane, and thylakoid lumen each of which is populated by specific sets of proteins.
More informationCancer. Throughout the life of an individual, but particularly during development, every cell constantly faces decisions.
Cancer Throughout the life of an individual, but particularly during development, every cell constantly faces decisions. Should it divide? Yes No--> Should it differentiate? Yes No-->Should it die? Yes-->Apoptosis
More informationCancer Genetics. What is Cancer? Cancer Classification. Medical Genetics. Uncontrolled growth of cells. Not all tumors are cancerous
Session8 Medical Genetics Cancer Genetics J avad Jamshidi F a s a U n i v e r s i t y o f M e d i c a l S c i e n c e s, N o v e m b e r 2 0 1 7 What is Cancer? Uncontrolled growth of cells Not all tumors
More informationSilibinin i activates p53-caspase-2 pathway and causes caspase-mediated cleavage of Cip1/p21 in apoptosis
Silibinin i activates p53-caspase-2 pathway and causes caspase-mediated cleavage of Cip1/p21 in apoptosis induction in bladder transitional-cell papilloma RT4 cells: Evidence for a regulatory loop between
More informationotherwise known as Cytotoxic T lymphocytes (CTLs)
MIT Biology Department 7.012: Introductory Biology - Fall 200 Instructors: Professor Eric Lander, Professor Robert A. Weinberg, Dr. Claudette Gardel NAME TA SEC 7.012 Problem Set 5 FRIDAY October 29, 2004
More informationTransformation of Normal HMECs (Human Mammary Epithelial Cells) into Metastatic Breast Cancer Cells: Introduction - The Broad Picture:
Transformation of Normal HMECs (Human Mammary Epithelial Cells) into Metastatic Breast Cancer Cells: Introduction - The Broad Picture: Spandana Baruah December, 2016 Cancer is defined as: «A disease caused
More informationCancer. Death Rates for the Main Causes of Death in the U.S. Leading Sites of New Cases & Deaths (2015 estimates in the U.S.)
11/25/17 Learning Goals for This Lecture Cancer - To recognize that cancer largely is a preventable disease. - To recognize that cancer is a disease of our own genes. Weimin Zhong, Ph.D. weimin.zhong@yale.edu
More informationGenetics and Cancer Ch 20
Genetics and Cancer Ch 20 Cancer is genetic Hereditary cancers Predisposition genes Ex. some forms of colon cancer Sporadic cancers ~90% of cancers Descendants of cancerous cells all cancerous (clonal)
More informationTITLE: A Mouse Model to Investigate the Role of DBC2 in Breast Cancer
AD Award Number: W81XWH-04-1-0325 TITLE: A Mouse Model to Investigate the Role of DBC2 in Breast Cancer PRINCIPAL INVESTIGATOR: Valerie Boka CONTRACTING ORGANIZATION: University of Texas Health Science
More informationBioSci 145A Lecture 15 - Oncogenes and Cancer
BioSci 145A Lecture 15 - Oncogenes and Cancer Topics we will cover today Introduction to normal and cancer cells Characteristics of cells in culture Cancerous changes in cells Viruses can harbor transforming
More informationTITLE: The Role of hcdc4 as a Tumor Suppressor Gene in Genomic Instability Underlying Prostate Cancer
AD Award Number: TITLE: The Role of hcdc4 as a Tumor Suppressor Gene in Genomic Instability Underlying Prostate Cancer PRINCIPAL INVESTIGATOR: Audrey van Drogen, Ph.D. CONTRACTING ORGANIZATION: Sidney
More informationReviewers' comments: Reviewer #1 (Remarks to the Author):
Reviewers' comments: Reviewer #1 (Remarks to the Author): In this study the authors analysed 18 deep penetrating nevi for oncogenic genomic changes (single nucleotide variations, insertions/deletions,
More informationNew England Medical Center Hospitals, Incorporated Boston, Massachusetts 02111
AD Award Number: DAMD17-02-1-0510 TITLE: A Molecular Connection Between Breast Cancer Proliferation and Metastasis Mediated by Akt Kinase PRINCIPAL INVESTIGATOR: Georg F. Weber, M.D. CONTRACTING ORGANIZATION:
More informationMITOCW ocw lec29
MITOCW ocw-7.013-lec29 The following content is provided by MIT OpenCourseWare under a Creative Commons license. Additional information about our license and MIT OpenCourseWare in general is available
More informationSUPPLEMENTARY INFORMATION
Figure S1 Induction of non-apoptotic death of SV40-transformed and primary DKO MEFs, and DKO thymocytes. (A-F) STS-induced non-apoptotic death of DKO MEF. (A, B) Reduced viability of DKO MEFs after exposure
More informationBiochemistry of Cancer and Tumor Markers
Biochemistry of Cancer and Tumor Markers The term cancer applies to a group of diseases in which cells grow abnormally and form a malignant tumor. It is a long term multistage genetic process. The first
More informationBIT 120. Copy of Cancer/HIV Lecture
BIT 120 Copy of Cancer/HIV Lecture Cancer DEFINITION Any abnormal growth of cells that has malignant potential i.e.. Leukemia Uncontrolled mitosis in WBC Genetic disease caused by an accumulation of mutations
More informationGenetics of Cancer Lecture 32 Cancer II. Prof. Bevin Engelward, MIT Biological Engineering Department
Genetics of Cancer Lecture 32 Cancer II rof. Bevin Engelward, MIT Biological Engineering Department Why Cancer Matters New Cancer Cases in 1997 Cancer Deaths in 1997 Genetics of Cancer: Today: What types
More informationCell Death & Renewal (part 2)
17 Cell Death & Renewal (part 2) Programmed Cell Death A major signaling pathway that promotes cell survival is initiated by the enzyme PI 3-kinase, which phosphorylates PIP2 to form PIP3, which activates
More informationControl of Cell Proliferation by Peptide Growth Factors. Autocrine Growth Factor Production Causes Malignant Transformation?
Control of Cell Proliferation by Peptide Growth Factors Autocrine Growth Factor Production Causes Malignant Transformation? Transforming Activities From Condition Media from a Tumor Cell Line Condition
More informationChapter 18- Oncogenes, tumor suppressors & Cancer
Chapter 18- Oncogenes, tumor suppressors & Cancer - Previously we have talked about cancer which is an uncontrolled cell proliferation and we have discussed about the definition of benign, malignant, metastasis
More informationPart-4. Cell cycle regulatory protein 5 (Cdk5) A novel target of ERK in Carb induced cell death
Part-4 Cell cycle regulatory protein 5 (Cdk5) A novel target of ERK in Carb induced cell death 95 1. Introduction The process of replicating DNA and dividing cells can be described as a series of coordinated
More informationChapter 9, Part 1: Biology of Cancer and Tumor Spread
PATHOPHYSIOLOGY Name Chapter 9, Part 1: Biology of Cancer and Tumor Spread I. Cancer Characteristics and Terminology Neoplasm new growth, involves the overgrowth of tissue to form a neoplastic mass (tumor).
More informationCancer. October is National Breast Cancer Awareness Month
Cancer October is National Breast Cancer Awareness Month Objectives 1: Gene regulation Explain how cells in all the different parts of your body develop such different characteristics and functions. Contrast
More informationFunctional Limitations
Regulation of the Cell Cycle Chapter 12 Pg. 228 245 Functional Limitations Various factors determine whether and when a cell divides. Two functional limitations for cell size limit growth or influence
More information2015 AP Biology Unit #4 Quiz 1 Cell Communication, Cancer and The Cell Cycle Week of November
Name: Class: Date: 2015 AP Biology Unit #4 Quiz 1 Cell Communication, Cancer and The Cell Cycle Week of 16-20 November Multiple Choice Identify the choice that best completes the statement or answers the
More informationCONTRACTING ORGANIZATION: Rush University Medical Center Chicago, IL 60612
AD Award Number: W81XWH-11-1-0302 TITLE: Yin and Yang of Heparanase in breast Tumor Initiation PRINCIPAL INVESTIGATOR: Xiulong Xu, Ph.D. CONTRACTING ORGANIZATION: Rush University Medical Center Chicago,
More informationTITLE: Role of Notch Signaling in Human Breast Cancer Pathogenesis. CONTRACTING ORGANIZATION: Indian Institute of Science Bangalore India
AD Award Number: DAMD17-03-1-0392 TITLE: Role of Notch Signaling in Human Breast Cancer Pathogenesis PRINCIPAL INVESTIGATOR: Annapoorni Rangarajan, Ph.D CONTRACTING ORGANIZATION: Indian Institute of Science
More informationSupplementary Material
Supplementary Material Summary: The supplementary information includes 1 table (Table S1) and 4 figures (Figure S1 to S4). Supplementary Figure Legends Figure S1 RTL-bearing nude mouse model. (A) Tumor
More informationChemotherapy Drugs: Less is More
Chemotherapy Drugs: Less is More Background BY: Noorain Shethwala and Sophia Oke Since chemotherapy was first recognized as a proven treatment for cancer, it has been the subject to intense scientific
More informationWhat causes cancer? Physical factors (radiation, ionization) Chemical factors (carcinogens) Biological factors (virus, bacteria, parasite)
Oncogenes What causes cancer? Chemical factors (carcinogens) Physical factors (radiation, ionization) Biological factors (virus, bacteria, parasite) DNA Mutation or damage Oncogenes Tumor suppressor genes
More informationComputational Systems Biology: Biology X
Bud Mishra Room 1002, 715 Broadway, Courant Institute, NYU, New York, USA L#4:(October-0-4-2010) Cancer and Signals 1 2 1 2 Evidence in Favor Somatic mutations, Aneuploidy, Copy-number changes and LOH
More informationLESSON 3.2 WORKBOOK. How do normal cells become cancer cells? Workbook Lesson 3.2
For a complete list of defined terms, see the Glossary. Transformation the process by which a cell acquires characteristics of a tumor cell. LESSON 3.2 WORKBOOK How do normal cells become cancer cells?
More informationLAMPvax DNA Vaccines as Immunotherapy for Cancer - Three Case Studies
LAMPvax DNA Vaccines as Immunotherapy for Cancer - Three Case Studies Cancer immunotherapy has emerged as a clinically validated tool for fighting certain kinds of cancers. These therapeutic cancer vaccines
More informationSrc-INACTIVE / Src-INACTIVE
Biology 169 -- Exam 1 February 2003 Answer each question, noting carefully the instructions for each. Repeat- Read the instructions for each question before answering!!! Be as specific as possible in each
More informationWhat would you observe if you fused a G1 cell with a S cell? A. Mitotic and pulverized chromosomes. B. Mitotic and compact G1 chromosomes.
What would you observe if you fused a G1 cell with a S cell? A. Mitotic and pulverized chromosomes. B. Mitotic and compact G1 chromosomes. C. Mostly non-compact G1 chromosomes. D. Compact G1 and G2 chromosomes.
More informationBio 401 Sp2014. Multiple Choice (Circle the letter corresponding to the correct answer)
MIDTERM EXAM KEY (60 pts) You should have 5 pages. Please put your name on every page. You will have 70 minutes to complete the exam. You may begin working as soon as you receive the exam. NOTE: the RED
More informationSupplementary Figure 1 CD4 + T cells from PKC-θ null mice are defective in NF-κB activation during T cell receptor signaling. CD4 + T cells were
Supplementary Figure 1 CD4 + T cells from PKC-θ null mice are defective in NF-κB activation during T cell receptor signaling. CD4 + T cells were isolated from wild type (PKC-θ- WT) or PKC-θ null (PKC-θ-KO)
More informationERK1/2/MAPK pathway-dependent regulation of the telomeric factor TRF2
ERK1/2/MAPK pathway-dependent regulation of the telomeric factor TRF2 SUPPLEMENTARY FIGURES AND TABLE Supplementary Figure S1: Conservation of the D domain throughout evolution. Alignment of TRF2 sequences
More information